NYSE:BSX - Boston Scientific Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $46.53
Forecasted Upside: 11.53 %
Number of Analysts: 17
Breakdown:
0 Sell Ratings
4 Hold Ratings
12 Buy Ratings
1 Strong Buy Ratings

^$41.72 As of 05/17/2021 01:00 AM ET

▲ +0.17 (0.41%)

1 month | 3 months | 12 months

Get New Boston Scientific Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for BSX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BSX

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

^$46.53

▲ +11.53% Upside Potential

This price target is based on 17 analysts offering 12 month price targets for Boston Scientific in the last 3 months. The average price target is $46.53, with a high forecast of $52.00 and a low forecast of $43.00. The average price target represents a 11.53% upside from the last price of $41.72.

Buy

The current consensus among 17 contributing investment analysts is to buy stock in Boston Scientific. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

1 strong buy ratings
17 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

11/24/2019

1 strong buy ratings
16 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

2/22/2020

2 strong buy ratings
21 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

5/22/2020

2 strong buy ratings
20 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

8/20/2020

2 strong buy ratings
19 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

11/18/2020

2 strong buy ratings
16 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

2/16/2021

1 strong buy ratings
16 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

4/17/2021

1 strong buy ratings
12 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

5/17/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
5/5/2021	Morgan Stanley	Boost Price Target	Overweight	$43.00 ➝ $51.00	Low	i
4/29/2021	Truist	Boost Price Target		$42.00 ➝ $50.00	Low	i
4/29/2021	Canaccord Genuity	Boost Price Target	Buy	$44.00 ➝ $49.00	Low	i
4/29/2021	Morgan Stanley	Boost Price Target	Overweight	$43.00 ➝ $51.00	Low	i
4/29/2021	Wells Fargo & Company	Boost Price Target	In-Line ➝ Overweight	$42.00 ➝ $50.00	Low	i
4/29/2021	Deutsche Bank Aktiengesellschaft	Boost Price Target	Hold	$39.00 ➝ $45.00	Low	i
4/21/2021	Atlantic Securities	Initiated Coverage	Overweight	$52.00	High	i
4/15/2021	Atlantic Securities	Initiated Coverage	Overweight	$52.00	High	i
2/12/2021	Needham & Company LLC	Boost Price Target	Buy	$43.00 ➝ $46.00	Low	i
2/4/2021	Raymond James	Boost Price Target	Strong-Buy	$39.00 ➝ $43.00	Low	i
2/3/2021	Piper Sandler	Boost Price Target	In-Line ➝ Overweight	$46.00 ➝ $48.00	High	i
2/1/2021	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Hold		Low	i
12/15/2020	Morgan Stanley	Boost Price Target	Overweight	$40.00 ➝ $43.00	Low	i
12/15/2020	The Goldman Sachs Group	Downgrade	Conviction-Buy ➝ Buy		Medium	i
12/8/2020	BTIG Research	Reiterated Rating	Buy		Low	i
11/18/2020	Truist	Lower Price Target		$47.00 ➝ $44.00	Medium	i
11/18/2020	Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell	Lower Price Target		$46.00 ➝ $43.00	Medium	i
11/18/2020	Smith Barney Citigroup	Lower Price Target		$46.00 ➝ $43.00	High	i
11/18/2020	Wells Fargo & Company	Lower Price Target	Overweight	$44.00 ➝ $41.00	High	i
11/18/2020	Morgan Stanley	Lower Price Target	Overweight	$41.00 ➝ $40.00	High	i
11/17/2020	Needham & Company LLC	Lower Price Target	Buy	$50.00 ➝ $43.00	High	i Rating by Michael Matson at Needham & Company LLC
10/29/2020	Morgan Stanley	Lower Price Target	Overweight	$48.00 ➝ $41.00	High	i
9/17/2020	Truist	Initiated Coverage	Buy	$47.00 ➝ $47.00	High	i
9/11/2020	Wolfe Research	Initiated Coverage	Market Perform	$46.00	Medium	i
7/30/2020	Stifel Nicolaus	Boost Price Target	Buy	$45.00 ➝ $47.00	Low	i Rating by Rick Wise at Stifel Nicolaus
7/30/2020	Jefferies Financial Group	Boost Price Target	Buy	$43.00 ➝ $46.00	Low	i
7/30/2020	Citigroup	Boost Price Target	Buy	$44.00 ➝ $46.00	Medium	i
7/30/2020	SVB Leerink	Boost Price Target	Market Perform	$40.00 ➝ $43.00	Medium	i Rating by D. Antalffy at SVB Leerink LLC
7/30/2020	Morgan Stanley	Boost Price Target	Overweight	$45.00 ➝ $48.00	Medium	i
7/29/2020	Needham & Company LLC	Reiterated Rating	Buy	$50.00	Medium	i Rating by Michael Matson at Needham & Company LLC
7/29/2020	Oppenheimer	Boost Price Target	Market Perform	$41.00 ➝ $43.00	Medium	i
6/24/2020	Stifel Nicolaus	Reiterated Rating	Buy	$45.00	Low	i Rating by Rick Wise at Stifel Nicolaus
5/13/2020	Argus	Boost Price Target	Buy	$40.00 ➝ $42.00	Low	i
4/30/2020	CSFB	Boost Price Target	Outperform	$42.00 ➝ $43.00	High	i
4/30/2020	Wells Fargo & Company	Boost Price Target	Overweight	$40.00 ➝ $41.00	Low	i
4/30/2020	Credit Suisse Group	Boost Price Target	Outperform	$42.00 ➝ $43.00	Low	i
4/30/2020	Citigroup	Boost Price Target	Buy	$40.00 ➝ $42.00	Medium	i
4/30/2020	UBS Group	Lower Price Target	Buy	$50.00 ➝ $45.00	Medium	i
4/30/2020	Stifel Nicolaus	Boost Price Target	Buy	$35.00 ➝ $45.00	Medium	i
4/30/2020	Raymond James	Boost Price Target	Strong-Buy	$42.00 ➝ $43.00	High	i
4/30/2020	Oppenheimer	Reiterated Rating	Hold	$46.00 ➝ $41.00	Low	i
4/29/2020	BTIG Research	Reiterated Rating	Buy	$44.00	Low	i Rating by Marie Thibault at BTIG Research
4/29/2020	Needham & Company LLC	Reiterated Rating	Buy	$46.00	Low	i Rating by Michael Matson at Needham & Company LLC
4/23/2020	SunTrust Banks	Lower Price Target	Buy	$28.00 ➝ $25.00	Low	i
4/22/2020	SVB Leerink	Downgrade	Outperform ➝ Market Perform	$40.00	Low	i Rating by D. Antalffy at SVB Leerink LLC
4/9/2020	Raymond James	Lower Price Target	Strong-Buy	$49.00 ➝ $42.00	High	i
4/2/2020	Piper Sandler	Reiterated Rating	Buy		Low	i Rating by Matthew O'Brien at Piper Sandler
4/2/2020	Needham & Company LLC	Lower Price Target	Buy	$53.00 ➝ $43.00	Medium	i
4/1/2020	The Goldman Sachs Group	Upgrade	Neutral ➝ Conviction-Buy	$46.00 ➝ $38.00	High	i
3/27/2020	Citigroup	Lower Price Target	Buy	$48.00 ➝ $40.00	Low	i
3/24/2020	Stifel Nicolaus	Lower Price Target	Buy	$47.00 ➝ $30.00	High	i
3/23/2020	Stephens	Lower Price Target	Overweight	$48.00 ➝ $35.00	High	i Rating by Chris Cooley at Stephens
3/9/2020	Cfra	Upgrade	Buy ➝ Strong-Buy	$50.00 ➝ $47.00	Low	i
3/6/2020	Credit Suisse Group	Lower Price Target	Outperform	$51.00 ➝ $46.00	High	i
3/4/2020	Citigroup	Initiated Coverage	Buy	$48.00	High	i
2/12/2020	The Goldman Sachs Group	Initiated Coverage	Neutral	$46.00	Low	i
2/6/2020	BTIG Research	Initiated Coverage	Buy	$46.00	Low	i
2/6/2020	Canaccord Genuity	Reiterated Rating	Buy	$58.00	Low	i
1/15/2020	Cowen	Reiterated Rating	Buy	$52.00	Medium	i Rating by Josh Jennings at Cowen Inc
1/14/2020	Piper Sandler	Reiterated Rating	Buy		Low	i Rating by Matthew O'Brien at Piper Sandler
12/30/2019	Cowen	Boost Price Target	Outperform	$47.00 ➝ $52.00	Low	i
12/20/2019	JPMorgan Chase & Co.	Boost Price Target	Overweight	$50.00 ➝ $55.00	Low	i
12/19/2019	Needham & Company LLC	Downgrade	Strong-Buy ➝ Buy	$53.00	Low	i Rating by Michael Matson at Needham & Company LLC
12/17/2019	Morgan Stanley	Boost Price Target	Overweight	$50.00 ➝ $51.00	Medium	i Rating by David Lewis at Morgan Stanley
12/16/2019	Wells Fargo & Company	Boost Price Target	Overweight	$48.00 ➝ $52.00	Low	i
10/25/2019	Guggenheim	Set Price Target	Buy	$53.00	N/A	i Rating by Christopher Pasquale at Guggenheim
10/23/2019	Needham & Company LLC	Reiterated Rating	Buy	$53.00	Medium	i Rating by Michael Matson at Needham & Company LLC
10/14/2019	Raymond James	Lower Price Target	Strong-Buy	$50.00 ➝ $48.00	Low	i
9/30/2019	Stephens	Set Price Target	Buy	$48.00	Low	i Rating by Chris Cooley at Stephens
9/6/2019	Stifel Nicolaus	Set Price Target	Buy	$47.00	High	i Rating by Rick Wise at Stifel Nicolaus
9/5/2019	JPMorgan Chase & Co.	Initiated Coverage	Overweight		Medium	i
9/3/2019	Barclays	Reiterated Rating	Overweight	$48.00	High	i
8/30/2019	Stifel Nicolaus	Set Price Target	Buy	$46.00	Low	i Rating by Rick Wise at Stifel Nicolaus
8/29/2019	Morgan Stanley	Set Price Target	Buy	$50.00	Low	i Rating by David Lewis at Morgan Stanley
7/31/2019	SVB Leerink	Set Price Target	Buy	$50.00	Low	i Rating by Danielle Antalffy at SVB Leerink LLC
7/25/2019	Raymond James	Boost Price Target	Strong-Buy	$48.00 ➝ $50.00	Medium	i
7/24/2019	Needham & Company LLC	Set Price Target	Buy	$46.00	Low	i Rating by Michael Matson at Needham & Company LLC
7/24/2019	BTIG Research	Set Price Target	Buy	$46.00	Low	i Rating by Sean Lavin at BTIG Research
7/24/2019	Piper Jaffray Companies	Set Price Target	Buy	$50.00	Low	i Rating by Matthew O'Brien at Piper Jaffray Companies
6/27/2019	Stifel Nicolaus	Boost Price Target	Buy ➝ In-Line	$44.00 ➝ $46.00	Medium	i
6/27/2019	Canaccord Genuity	Boost Price Target	Buy	$43.00 ➝ $46.00	Medium	i
6/27/2019	Jefferies Financial Group	Boost Price Target	Buy ➝ Positive	$44.00 ➝ $48.00	Medium	i
6/27/2019	Piper Jaffray Companies	Boost Price Target	Overweight	$42.00 ➝ $50.00	Medium	i
6/18/2019	Wells Fargo & Company	Boost Price Target	Outperform	$42.00 ➝ $45.00	Medium	i
5/13/2019	Evercore ISI	Upgrade	In-Line ➝ Outperform	$36.20	Low	i
5/13/2019	Needham & Company LLC	Reiterated Rating	Buy	$43.00	Medium	i
4/25/2019	BTIG Research	Reiterated Rating	Buy		High	i
4/17/2019	Canaccord Genuity	Lower Price Target	Buy ➝ Buy	$45.00 ➝ $43.00	Medium	i
2/13/2019	Argus	Boost Price Target	Buy	$43.00 ➝ $45.00	Medium	i Rating by Jasper Hellweg at Argus
2/11/2019	Canaccord Genuity	Reiterated Rating	Buy	$45.00	Medium	i
2/8/2019	SunTrust Banks	Reiterated Rating	Buy	$47.00	Low	i
2/8/2019	Guggenheim	Reiterated Rating	Buy	$48.00	Low	i
2/6/2019	Needham & Company LLC	Reiterated Rating	Buy	$43.00	Low	i
1/8/2019	Needham & Company LLC	Reiterated Rating	Buy	$43.00	Medium	i
12/17/2018	Credit Suisse Group	Initiated Coverage	Outperform	$42.00	Low	i
11/27/2018	UBS Group	Initiated Coverage	Buy ➝ Buy	$45.00	High	i
11/21/2018	Oppenheimer	Reiterated Rating	Hold		Low	i Rating by Steven Lichtman at Oppenheimer Holdings Inc.
11/21/2018	BTIG Research	Reiterated Rating	Buy		Low	i
11/20/2018	SunTrust Banks	Boost Price Target	Buy	$44.00	Low	i
11/19/2018	Stephens	Reiterated Rating	In-Line ➝ Market Perform	$40.00	Medium	i
11/16/2018	Guggenheim	Boost Price Target	Buy	$45.00	Low	i
10/26/2018	Argus	Boost Price Target	Buy ➝ Buy	$41.00 ➝ $43.00	Low	i Rating by Jasper Hellweg at Argus
10/25/2018	Canaccord Genuity	Boost Price Target	Buy	$40.00 ➝ $42.00	Low	i
10/25/2018	BTIG Research	Reiterated Rating	Buy	$45.00	Medium	i
10/24/2018	Oppenheimer	Set Price Target	Hold	$38.00	Medium	i Rating by Steven Lichtman at Oppenheimer Holdings Inc.
10/22/2018	Cowen	Set Price Target	Buy	$39.00 ➝ $42.00	Low	i
10/16/2018	BTIG Research	Reiterated Rating	Buy	$45.00	High	i
10/15/2018	Barclays	Initiated Coverage	Overweight ➝ Overweight	$43.00	High	i
10/15/2018	Royal Bank of Canada	Boost Price Target	Top Pick	$42.00	High	i
10/2/2018	Morgan Stanley	Boost Price Target	Overweight ➝ Overweight	$38.00 ➝ $48.00	Low	i
9/25/2018	Oppenheimer	Reiterated Rating	Hold		Medium	i Rating by Steven Lichtman at Oppenheimer Holdings Inc.
9/17/2018	Wells Fargo & Company	Boost Price Target	Outperform	$38.00 ➝ $42.00	Low	i
9/7/2018	Needham & Company LLC	Reiterated Rating	Strong-Buy ➝ Strong-Buy	$39.00 ➝ $43.00	Low	i
9/5/2018	Argus	Boost Price Target	Buy	$41.00	Low	i
9/4/2018	Raymond James	Boost Price Target	Strong-Buy ➝ Strong-Buy	$40.00 ➝ $41.00	Low	i
9/4/2018	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$34.00 ➝ $42.00	Low	i
7/27/2018	Guggenheim	Reiterated Rating	Buy	$43.00	Low	i
7/26/2018	Stifel Nicolaus	Reiterated Rating	Buy	$37.00	Low	i
7/26/2018	Jefferies Financial Group	Reiterated Rating	Hold	$34.00	Low	i
7/26/2018	Morgan Stanley	Boost Price Target	Overweight ➝ Overweight	$33.00 ➝ $38.00	Low	i
7/26/2018	Piper Jaffray Companies	Boost Price Target	Overweight	$38.00	Low	i
7/23/2018	Royal Bank of Canada	Boost Price Target	Top Pick	$36.00	Low	i
7/23/2018	SunTrust Banks	Boost Price Target	Buy	$39.00	Low	i
7/10/2018	BMO Capital Markets	Boost Price Target	Outperform	$36.00	High	i
7/6/2018	Needham & Company LLC	Reiterated Rating	Strong-Buy		Medium	i
6/27/2018	Sanford C. Bernstein	Initiated Coverage	Outperform	$38.00	Low	i
6/7/2018	Argus	Boost Price Target	Buy ➝ Buy	$32.00 ➝ $36.00	Medium	i
5/1/2018	Citigroup	Boost Price Target	Buy ➝ Buy	$32.00 ➝ $34.00	Low	i
4/26/2018	Raymond James	Boost Price Target	Strong-Buy ➝ Strong-Buy	$32.00 ➝ $34.00	Low	i
4/26/2018	Jefferies Financial Group	Reiterated Rating	Hold	$31.00	Low	i
4/26/2018	Needham & Company LLC	Boost Price Target	Strong-Buy ➝ Strong-Buy	$35.00 ➝ $36.00	Low	i
4/26/2018	SVB Leerink	Boost Price Target	Outperform ➝ Outperform	$32.00 ➝ $33.00	Low	i
4/26/2018	JPMorgan Chase & Co.	Boost Price Target	Overweight ➝ Overweight	$31.00 ➝ $32.00	Low	i
4/25/2018	Canaccord Genuity	Reiterated Rating	Buy	$36.00	Low	i
4/5/2018	Bank of America	Boost Price Target	Buy ➝ Buy	$30.00 ➝ $34.00	Low	i
3/27/2018	Needham & Company LLC	Reiterated Rating	Buy	$35.00	High	i
3/19/2018	Morgan Stanley	Boost Price Target	Overweight ➝ Overweight	$30.00 ➝ $33.00	Low	i
3/5/2018	Royal Bank of Canada	Reiterated Rating	Top Pick	$32.00	Medium	i
2/23/2018	Piper Jaffray Companies	Initiated Coverage	Overweight ➝ Overweight	$31.00	Medium	i
2/2/2018	Jefferies Financial Group	Reiterated Rating	Hold ➝ Neutral		Low	i
1/17/2018	Canaccord Genuity	Reiterated Rating	Buy		Low	i
1/16/2018	Needham & Company LLC	Reiterated Rating	Buy	$32.00	Low	i
1/10/2018	Barclays	Reiterated Rating	Buy	$32.00	Low	i
1/5/2018	Royal Bank of Canada	Upgrade	Outperform ➝ Top Pick		Medium	i
1/3/2018	Evercore ISI	Initiated Coverage	In ➝ In-Line	$27.00	Medium	i
12/12/2017	BMO Capital Markets	Reiterated Rating	Buy	$32.00	Low	i
12/8/2017	Needham & Company LLC	Upgrade	Buy ➝ Strong-Buy	$25.04 ➝ $32.00	Low	i
12/4/2017	SunTrust Banks	Set Price Target	Buy	$33.00	Low	i Rating by Bruce Nudell at SunTrust Banks, Inc.
11/30/2017	Cowen	Set Price Target	Buy	$31.00	Low	i Rating by Josh Jennings at Cowen Inc
11/30/2017	BTIG Research	Upgrade	Neutral ➝ Buy	$31.00	Medium	i
11/29/2017	BMO Capital Markets	Reiterated Rating	Buy	$31.00	Medium	i
11/29/2017	JPMorgan Chase & Co.	Reiterated Rating	Buy		Low	i
11/29/2017	Oppenheimer	Reiterated Rating	Hold		High	i Rating by Steven Lichtman at Oppenheimer Holdings Inc.
11/29/2017	Canaccord Genuity	Lower Price Target	Buy ➝ Buy	$36.00 ➝ $35.00	High	i
11/7/2017	Royal Bank of Canada	Reiterated Rating	Buy	$31.00	N/A	i
10/31/2017	SunTrust Banks	Set Price Target	Buy	$34.00	N/A	i Rating by Bruce Nudell at SunTrust Banks, Inc.
10/27/2017	BMO Capital Markets	Boost Price Target	Outperform	$30.00 ➝ $32.00	N/A	i
10/24/2017	Canaccord Genuity	Initiated Coverage	Buy ➝ Buy	$36.00	N/A	i
10/13/2017	BMO Capital Markets	Reiterated Rating	Buy	$30.00	N/A	i
10/3/2017	Needham & Company LLC	Reiterated Rating	Buy	$32.00	Low	i
10/2/2017	SunTrust Banks	Reiterated Rating	Buy	$34.00	Medium	i
9/25/2017	Stifel Nicolaus	Reiterated Rating	Buy	$32.00	Low	i
9/7/2017	Jefferies Financial Group	Reiterated Rating	Hold		Low	i
9/1/2017	Royal Bank of Canada	Reiterated Rating	Buy	$31.00	N/A	i
8/9/2017	Oppenheimer	Reiterated Rating	Hold		Medium	i Rating by Steven Lichtman at Oppenheimer Holdings Inc.
8/1/2017	UBS Group	Reiterated Rating	Buy	$30.00 ➝ $31.00	Low	i
7/30/2017	Stifel Nicolaus	Reiterated Rating	Buy	$32.00	Medium	i
7/28/2017	Oppenheimer	Set Price Target	Hold	$29.00	Low	i Rating by Steven Lichtman at Oppenheimer Holdings Inc.
7/28/2017	Cowen	Reiterated Rating	Buy	$31.00 ➝ $32.00	Low	i
7/17/2017	Cowen	Reiterated Rating	Outperform	$31.00	Low	i
7/12/2017	Royal Bank of Canada	Reiterated Rating	Buy	$31.00	Low	i
6/28/2017	JPMorgan Chase & Co.	Reiterated Rating	Overweight	$27.00 ➝ $31.00	Low	i
6/28/2017	Stifel Nicolaus	Boost Price Target	Hold	$30.00 ➝ $32.00	Low	i
6/28/2017	Jefferies Financial Group	Reiterated Rating	Hold	$28.00	Low	i
6/28/2017	Oppenheimer	Reiterated Rating	Hold		Low	i Rating by Steven Lichtman at Oppenheimer Holdings Inc.
6/28/2017	Barclays	Boost Price Target	Overweight ➝ Overweight	$30.00 ➝ $31.00	Low	i
6/22/2017	Needham & Company LLC	Boost Price Target	Buy	$30.00 ➝ $32.00	Low	i
6/21/2017	BMO Capital Markets	Reiterated Rating	Buy	$30.00	Low	i
6/16/2017	Wells Fargo & Company	Reiterated Rating	Outperform	$29.50 ➝ $31.00	Low	i
6/9/2017	Royal Bank of Canada	Reiterated Rating	Ourperform	$31.00 ➝ $29.00	Low	i
6/9/2017	Royal Bank of Canada	Boost Price Target	Outperform	$29.00 ➝ $31.00	Low	i
5/16/2017	The Goldman Sachs Group	Initiated Coverage	Neutral ➝ Neutral	$28.00	Low	i
4/28/2017	Stifel Nicolaus	Boost Price Target	Buy	$28.00 ➝ $30.00	Low	i
4/28/2017	Cowen	Boost Price Target	Outperform	$29.00 ➝ $31.00	Low	i
4/28/2017	Evercore ISI	Boost Price Target	Outperform	$26.50 ➝ $28.50	Low	i
4/28/2017	Oppenheimer	Set Price Target	Hold	$27.00	Low	i Rating by Steven Lichtman at Oppenheimer Holdings Inc.
4/27/2017	Needham & Company LLC	Reiterated Rating	Buy ➝ Buy	$29.00 ➝ $30.00	Low	i
4/12/2017	Guggenheim	Reiterated Rating	Buy		Low	i Rating by Christopher Pasquale at Guggenheim
4/7/2017	Jefferies Financial Group	Boost Price Target	Hold	$26.00 ➝ $28.00	Low	i
2/23/2017	Oppenheimer	Reiterated Rating	Hold		N/A	i Rating by Steven Lichtman at Oppenheimer Holdings Inc.
2/23/2017	Needham & Company LLC	Reiterated Rating	Buy	$29.00	N/A	i
2/23/2017	Northland Securities	Reiterated Rating	Positive		N/A	i
2/5/2017	BTIG Research	Reiterated Rating	Hold		N/A	i
2/3/2017	Oppenheimer	Set Price Target	Hold	$25.00 ➝ $26.00	N/A	i Rating by Steven Lichtman at Oppenheimer Holdings Inc.
2/3/2017	Jefferies Financial Group	Reiterated Rating	Hold	$26.00	N/A	i
2/2/2017	Needham & Company LLC	Boost Price Target	Buy	$28.00 ➝ $29.00	N/A	i
1/8/2017	BTIG Research	Reiterated Rating	Neutral		N/A	i
10/14/2016	Royal Bank of Canada	Reiterated Rating	Outperform	$28.00	N/A	i Rating by Glenn Novarro at Royal Bank of Canada
10/6/2016	Citigroup	Boost Price Target	Buy	$28.00 ➝ $29.00	N/A	i
9/1/2016	Argus	Upgrade	Hold ➝ Buy	$23.82 ➝ $33.00	N/A	i Rating by David Toung at Argus
8/3/2016	Citigroup	Boost Price Target	Buy	$26.00 ➝ $28.00	N/A	i
7/31/2016	Evercore ISI	Reiterated Rating	Buy	$25.50 ➝ $26.00	N/A	i
7/29/2016	Royal Bank of Canada	Reiterated Rating	Buy	$28.00	N/A	i
7/29/2016	JPMorgan Chase & Co.	Boost Price Target	Overweight	$24.00 ➝ $27.00	N/A	i Rating by Michael Weinstein at JPMorgan Chase & Co.
7/29/2016	Credit Suisse Group	Reiterated Rating	Buy		N/A	i
7/29/2016	SVB Leerink	Reiterated Rating	Buy		N/A	i Rating by Danielle Antalffy at SVB Leerink LLC
7/29/2016	Jefferies Financial Group	Boost Price Target	Hold	$21.00 ➝ $24.00	N/A	i
7/29/2016	Wedbush	Boost Price Target	Neutral	$23.00 ➝ $25.00	N/A	i
7/29/2016	Needham & Company LLC	Boost Price Target	Buy	$26.00 ➝ $28.00	N/A	i Rating by Michael Matson at Needham & Company LLC
7/28/2016	Benchmark	Boost Price Target	Buy	$25.00 ➝ $31.00	N/A	i Rating by Jan Wald at Benchmark Co.
7/17/2016	JPMorgan Chase & Co.	Reiterated Rating	Buy		N/A	i Rating by Michael Weinstein at JPMorgan Chase & Co.
7/5/2016	UBS Group	Reiterated Rating	Buy	$25.00	N/A	i Rating by Matt Miksic at UBS Group AG
6/21/2016	Piper Jaffray Companies	Reiterated Rating	Overweight	$26.00	N/A	i
6/17/2016	SVB Leerink	Reiterated Rating	Buy	$25.50 ➝ $27.50	N/A	i Rating by Danielle Antalffy at SVB Leerink LLC
6/8/2016	Guggenheim	Initiated Coverage	Buy	$26.00	N/A	i
5/25/2016	Piper Jaffray Companies	Reiterated Rating	Overweight	$26.00	N/A	i
5/23/2016	BTIG Research	Downgrade	Buy ➝ Neutral	$24.20	N/A	i Rating by Sean Lavin at BTIG Research

(Data available from 5/18/2016 forward)

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Today's Range

Now: $41.72

$41.23

$41.82

50 Day Range

MA: $41.18

$38.22

$44.24

52 Week Range

Now: $41.72

$32.99

$44.63

Volume

5,549,238 shs

Average Volume

9,200,281 shs

Market Capitalization

$59.28 billion

P/E Ratio

15.98

Dividend Yield

N/A

Beta

0.87

Frequently Asked Questions

What sell-side analysts currently cover shares of Boston Scientific?

The following Wall Street analysts have issued reports on Boston Scientific in the last twelve months: Atlantic Securities, BTIG Research, Canaccord Genuity, Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., Morgan Stanley, Needham & Company LLC, Oppenheimer Holdings Inc., Piper Sandler, Raymond James, Smith Barney Citigroup, Stifel Nicolaus, SVB Leerink LLC, The Goldman Sachs Group, Inc., TheStreet, Truist, Wells Fargo & Company, Wolfe Research, and Zacks Investment Research.
View the latest analyst ratings for BSX.

What is the current price target for Boston Scientific?

17 Wall Street analysts have set twelve-month price targets for Boston Scientific in the last year. Their average twelve-month price target is $46.53, suggesting a possible upside of 11.5%. Atlantic Securities has the highest price target set, predicting BSX will reach $52.00 in the next twelve months. Oppenheimer Holdings Inc. has the lowest price target set, forecasting a price of $43.00 for Boston Scientific in the next year.
View the latest price targets for BSX.

What is the current consensus analyst rating for Boston Scientific?

Boston Scientific currently has 4 hold ratings, 12 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe BSX will outperform the market and that investors should add to their positions of Boston Scientific.
View the latest ratings for BSX.

What other companies compete with Boston Scientific?

Other companies that are similar to Boston Scientific include Abbott Laboratories, Medtronic, Intuitive Surgical, Stryker, Becton, Dickinson and, Edwards Lifesciences, IDEXX Laboratories, Baxter International, DexCom, ResMed, Teleflex, STERIS, Hologic, Insulet and Abiomed.

How do I contact Boston Scientific's investor relations team?

Boston Scientific's physical mailing address is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. The medical equipment provider's listed phone number is (508) 683-4000 and its investor relations email address is [email protected] The official website for Boston Scientific is www.bostonscientific.com.